What is the Share Price of Sun Pharmaceutical Industries Ltd?

Sun Pharmaceutical Industries Ltd share price is ₹1,764.75 As on 25 March, 2025|22:20

Home
>
Stocks
>
Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd Share Price

Q: What is the Market Cap of Sun Pharmaceutical Industries Ltd?

The Market Cap of Sun Pharmaceutical Industries Ltd is ₹428,161 As on 25 March, 2025|22:20

Q: What is PE Ratio of Sun Pharmaceutical Industries Ltd?

The P/E ratio of Sun Pharmaceutical Industries Ltd is 36.3 As on 25 March, 2025|22:20

Q: What is PB Ratio of Sun Pharmaceutical Industries Ltd?

The PB ratio of Sun Pharmaceutical Industries Ltd is 6.13 As on 25 March, 2025|22:20

₹ 1,764.75 -20.05 (-1.12%)
Updated on 25-03-2025 5:38 PM

Stock Rating

Pros 3

Cons 4

Option Chain

Sun Pharmaceutical Industries Ltd Price Performance

Day's Low
₹1,758.50

Day's High
₹1,795.95

₹ 1,764.75

52-w low
₹1,377.20

52-w high
₹1,960.35

1,764.75

Day's open
₹1,784.80
Previous close
₹1,784.80
VWAP
₹1,770.77
Lower price band
₹1,606.35
Upper price band
₹1,963.25

Today's Market Action

The last traded share price of Sun Pharmaceutical Industries Ltd was 1,764.75 down by -1.12% on the NSE. Its last traded stock price on BSE was 1,766 down by -1.08%. The total volume of shares on NSE and BSE combined was 1,534,311 shares. Its total combined turnover was Rs 271.69 crores.

Sun Pharmaceutical Industries Ltd Medium and Long Term Market Action

Sun Pharmaceutical Industries Ltd hit a 52-week high of 1,960.35 on 30-09-2024 and a 52-week low of 1,377.20 on 04-06-2024. The stock price of Sun Pharmaceutical Industries Ltd is up by 8% over the last one month. It is up by 9.2% over the last one year. Don't forget to check the full stock price history in the table below.

Sun Pharmaceutical Industries Ltd Fundamentals

Market Cap (Cr): 428161
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Sun Pharmaceutical Industries Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Sun Pharmaceutical Industries Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Sun Pharmaceutical Industries Ltd

Data not available.

Sun Pharmaceutical Industries Ltd FAQ's

What is Share Price of Sun Pharmaceutical Industries Ltd?

What is the Market Cap of Sun Pharmaceutical Industries Ltd?

What is PE Ratio of Sun Pharmaceutical Industries Ltd?

What is PB Ratio of Sun Pharmaceutical Industries Ltd?

What is the CAGR of Sun Pharmaceutical Industries Ltd?

How to Buy Sun Pharmaceutical Industries Ltd Share?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Great Cash Conversion of Profits
The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 87.41% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
High Pricing Power
The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.04. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.61. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 178 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(25/03/2025)

Margin of Safety Index: High

90.70%

90.70% People are bullish about Sun Pharmaceutical Industries Ltd

9.30%

9.30 % People are bearish about Sun Pharmaceutical Industries Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %